Synopsys set to wipe out 2025 gains as shares tank on China business woes

Synopsys (SNPS) shares plummeted nearly 35%, erasing 2025 gains, after the chip design software provider reported a Q3 revenue miss of $1.74 billion, primarily attributing the shortfall to U.S. export restrictions impacting its China business and challenges with a major foundry customer. This significant decline, which also saw peer Cadence Design Systems (CDNS) fall 7%, underscores the acute financial vulnerability of semiconductor industry players to escalating Sino-U.S. trade tensions and broader industry headwinds.

Analysis

Synopsys (SNPS) shares plummeted nearly 35%, erasing all 2025 gains, following the announcement of third-quarter revenue of $1.74 billion, which missed LSEG analyst estimates. The revenue shortfall is directly attributed to two primary headwinds: geopolitical tensions and customer-specific challenges. CEO Sassine Ghazi cited U.S. export restrictions on chip design software to China, a market representing over 10% of revenue for key industry players, which disrupted business for over a month. Although these specific curbs were lifted in July, the company noted that tariff uncertainty persists, indicating a continued risk to a material portion of its revenue. Compounding this, Synopsys acknowledged weakness from a major foundry customer, strongly implied to be Intel (INTC), which has publicly scaled back its chip manufacturing projects. The market's reaction was not isolated, as peer Cadence Design Systems (CDNS) also saw its shares decline by nearly 7%, suggesting investors are repricing the entire chip design software sector to account for heightened geopolitical risk and potential client-side slowdowns.

Key Decisions for Investors

• Investors should re-evaluate exposure to SNPS and the broader chip design sector, as the stock's sharp decline reflects a new market reality where U.S.-China trade policy poses a direct and material threat to revenue.
• Monitor any further announcements from Intel regarding its foundry ambitions, as continued project cancellations or slowdowns would signal a persistent headwind for Synopsys's recovery.
• While the 35% price drop may appear to be a buying opportunity, it is critical to assess whether the current valuation adequately discounts the dual risks of ongoing geopolitical uncertainty and fundamental weakness from a key customer before considering a position.